1. Copyright © 2000 American Medical Association. All rights reserved.
From: Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs ChlorthalidoneThe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
JAMA. 2000;283(15): doi: /jama
Figure Legend:
ALLHAT indicates Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial; CHD, coronary heart disease.
Date of download: 10/29/2017
Copyright © 2000 American Medical Association. All rights reserved.

2. Copyright © 2000 American Medical Association. All rights reserved.
From: Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs ChlorthalidoneThe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
JAMA. 2000;283(15): doi: /jama
Figure Legend:
ALLHAT indicates Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial.
Date of download: 10/29/2017
Copyright © 2000 American Medical Association. All rights reserved.

3. Copyright © 2000 American Medical Association. All rights reserved.
From: Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs ChlorthalidoneThe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
JAMA. 2000;283(15): doi: /jama
Figure Legend:
Kaplan-Meier estimates are shown for coronary heart disease (primaryoutcome; P=.71), all-cause mortality (P=.56), combined cardiovascular disease (P<.001),and congestive heart failure (P<.001).
Date of download: 10/29/2017
Copyright © 2000 American Medical Association. All rights reserved.